Aberrant Methylation Inactivates Transforming Growth Factor β Receptor I in Head and Neck Squamous Cell Carcinoma

Background. Alterations in TGF-β signaling are common in head and neck cancer (HNSCC). Mutations in TGF-β type II receptor (TβR-II) occur frequently in HNSCC while TGF-β type I receptor (TβR-I) mutations are rare, suggesting that other molecular alterations in the TGF-β pathway are likely. To identi...

Full description

Bibliographic Details
Main Authors: Teresita Muñoz-Antonia, Mariclara Torrellas-Ruiz, Jonathan Clavell, Linda A. Mathews, Carlos A. Muro-Cacho, Adriana Báez
Format: Article
Language:English
Published: Hindawi Limited 2009-01-01
Series:International Journal of Otolaryngology
Online Access:http://dx.doi.org/10.1155/2009/848695